30-day notification
Understand the planning deadline and filing boundary.
Official sources are linked where cited · Preliminary guidance; no qualified legal or regulatory review. Editorial method and review status
STRUCTURE/FUNCTION CLAIMS
A disclaimer does not repair a disease claim or prove that a structure/function claim is substantiated. Classify the exact wording first, then review the statutory disclaimer, presentation, notification, and evidence together.
Open the claims checkerFor covered dietary supplement statements, 21 CFR 101.93(c) distinguishes the singular disclaimer below from the plural version. A general product advertisement is not automatically within this supplement route.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
| Presentation question | Saved rule text to check |
|---|---|
| Next to a covered statement | Adjacent, with no intervening material, or linked by a matching symbol at the end of each statement. |
| Different panels or pages | The regulation retains the panel/page wording. Review the FDA enforcement policy below for product-label panels; do not assume a waiver for other labeling pages. When not adjacent, review the box requirement. |
| Physical type size | Paragraph (e) requires boldface letters no smaller than 1/16 inch. A CSS size or enlarged PDF is not a physical print measurement. |
Layout-only example: Claim A* and Claim B* on one panel point to the same * beside the boxed plural disclaimer on that panel. Review other panels in light of the FDA enforcement policy below. This schematic does not establish that either claim is permissible or substantiated.
21 CFR 101.93(c)–(e), saved October 6 snapshot
The regulation still contains a panel/page requirement. FDA announced enforcement discretion on December 11, 2025 for repeating the disclaimer on every claim-bearing product-label panel; the letter does not waive inclusion on the label, linkage to each claim or other requirements. Do not extend this policy to every page of other labeling.
“This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”
21 CFR 101.93 contains presentation rules for this disclaimer. When a label or labeling contains more than one covered statement, the regulation also addresses how the disclaimer may be linked to the statements. Review the current text before final artwork approval.
Keep every claim body with its asterisk, symbol, footnote, qualifier, and panel location. This is especially important for OCR: extracting the sentence while losing the linked qualifier can change the apparent meaning. Review website, marketplace, advertising, and social copy separately because the label disclaimer does not automatically qualify every external statement.
Understand the planning deadline and filing boundary.
Keep claims, directions, and safety text aligned.
Check claims after formula and panel review.
Editorial examples updated . Source-version limits remain unchanged; qualified professional review pending.